Advances in Traditional Medicine

  • 제6권2호
  • /
  • Pages.69-78
  • /
  • 2006
  • /
  • 2662-4052(pISSN)
  • /
  • 2662-4060(eISSN)
경희대학교 융합한의과학연구소 (Kyung Hee Oriental Medicine Research Center)
권호 표지
DOI QR코드

DOI QR Code

The phyto-oestrogens: its anticarcinogenic and antioxidant activity-a review

  • Widyarini, Sitarina (Department of Veterinary Pathology, Faculty of Veterinary Medicine, Gadjah Mada University) ;
  • Reeve, Vivienne E. (Faculty of Veterinary Science, University of Sydney)
  • 발행 : 2006.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The isoflavonoids comprise a group of phyto-oestrogens that have useful biological activities including oestrogenic, antioxidant and anticancer. As dietary components for humans, they are bioavailable from leguminous vegetables (such as genistein from soybean), and have been well-documented to have numerous health benefits. A wide range of epidemiological studies in humans and limited studies in animals have identified isoflavonoids as potential chemopreventive agents against hormone-dependent cancers. Therefore, an attempt has been made through this review to summarise the information in the mechanisms aspect of isoflavonoid phyto-oestrogens in inhibiting cancer in vitro and in vivo in the models of human cancers.

키워드

참고문헌

  1. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. (2001) Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22, 1667-1673. https://doi.org/10.1093/carcin/22.10.1667
  2. Adlercreutz H, Mazur W. (1997) Phyto-oestrogens and Western diseases. Annals. Med. 29, 95-120.
  3. Adlercreutz H, Fotsis T, Kurzer MS, Wahala K, Makela T, Hase T. (1995) Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Annal. Biochem. 225, 101-108. https://doi.org/10.1006/abio.1995.1114
  4. Adlercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G, Base T. (1993) Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scan. J. Clin. Lab. Inves. 215, 5-18.
  5. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T, Okada H. (1991) Urinary excretion of lignans and isoflavonoid phyto-oestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 54, 1093-1100.
  6. Adlercreutz H. (1995) Phyto-oestrogens: Epidemiology and a possible role in cancer protection. Environ. Health Perspectives 103, 103-112.
  7. Adlercreutz H. (1990) Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations. Scan. J. Clin. Lab. Inves. 201, 3-23.
  8. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M,. Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595.
  9. Arora A, Nair MG, Strasburg GM. (1998) Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356, 133-141. https://doi.org/10.1006/abbi.1998.0783
  10. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KD. (1982) The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman] in human urine. Biochem. J. 201, 353-357.
  11. Bannwart C, Fotsis T, Heikkinen R, Adlercreutz H. (1989) Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin. Chim. Acta 136, 165-172. https://doi.org/10.1016/0009-8981(84)90288-2
  12. Bannwart C, Adlercreutz H, Wahala K, Brunow G, Hase T. (1984) Detection and identification of the plant lignans lariciresinol, isolariciresinol and secoisolariciresinol in human urine. Clin. Chim. Acta 180, 293-301. https://doi.org/10.1016/0009-8981(89)90011-9
  13. Blumel JO, Castelo-Branco C, Gonzalez P, Moyano C, Iturriaga M, Videla L, Sajuan A, Cano A. (2000) Transdermal estrogens do not appears to modify the extent of lesional areas of aortic atherosclerosis in oophoriectomized rabbits on a cholesterol-rich diet. Atherosclerosis 148, 303-308. https://doi.org/10.1016/S0021-9150(99)00277-4
  14. Booth C, Hargreaves DF, Hadfield JA, McGown AT, Potten CS. (1999) Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. Br. J. Cancer 80, 1550-1557. https://doi.org/10.1038/sj.bjc.6690559
  15. Cai QY, We HC. (1996) Effect of dietary genistein on antioxidant enzyme activities in Sencar mice. Nutr. Cancer 25, 1-7.
  16. Cai QY, Rahn RO, Zhang RW. (1997) Dietary flavonoids, quercetin, luteloin, and genistein reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett. 119, 99-107. https://doi.org/10.1016/S0304-3835(97)00261-9
  17. Constantinou AI, Krygier AE, Mehta RR. (1998) Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am. J. Clin. Nutr. 68, 1426S-1430S.
  18. Constantinou AI, Mehta RG, Vaughan A. (1996) Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 16, 3293-3298.
  19. Davis SR, Murkies AL, Wilcox G. (1998) Phytoestrogens in clinical practice. Integr. Med. 1, 27-34. https://doi.org/10.1016/S1096-2190(98)00019-5
  20. Ford LG, Bawley OW, Pearlman JA. (1994) The potential for hormonal prevention trials. Cancer 74, 2726-2733. https://doi.org/10.1002/1097-0142(19941101)74:9+<2726::AID-CNCR2820741823>3.0.CO;2-S
  21. Franke AA, Custer LJ, Tanaka Y. (1998) Isoflavones in human breast milk and other fluids. Am. J. Clin. Nutr. 68, 1466s-1473s.
  22. Fritz WA, Coward L, Wang J, Lamartiniere CA. (1998). Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19, 2151-2158. https://doi.org/10.1093/carcin/19.12.2151
  23. Gavaler JS, Galvao-Teles A, Monteiro E, Van Thiel D, Rosenblum E. (1991) Clinical responses to the administration of bourboun phyto-oestrogens to normal postmenoposal women. Hepatol. 14, 87A.
  24. Hellstrom M, Haggman M, Brandstedt S. (1993) Histopathological changes in androgen-deprived localised prostatic canter. A study of total prostatectomy specimens, Eur. Urol. 24, 461-465.
  25. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58, 3833-3038.
  26. Huang J, Nasr M, Kim, Y, Matthews HR. (1992) Genistein inhibits protein histidine kinase. J. Biol. Chem. 267, 15511-15515.
  27. Issoherranen K, Punnonen K, Jansen C, Outila P. (1999) Ultraviolet irradiation induced cyclooxygenase-2 expression in keratinocytes. Br. J. Dermatol. 140, 1017-1022. https://doi.org/10.1046/j.1365-2133.1999.02897.x
  28. Jenkins DJ, Kendall CW, Garsetti M, Rosenberg-Zand RS, Jacson CJ, Agarawal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, Vidgen E. (2000) Effect of soy protein foods on low-density lipoprotein oxidation and ex-vivo sex hormone receptor activity-acontrolled crossover trial. Metab. Clin. Exp. 49, 537-543.
  29. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, Gmeiner BM. (1997) Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arteriosclerosis Throm. Vas. Biol. 17, 2868-2874.
  30. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. (1995) The variable metabolic response to dietary isoflavones in human. Proc. Soc. Exp. Biol. Med. 208, 40-43.
  31. Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta 223, 9-22. https://doi.org/10.1016/0009-8981(93)90058-C
  32. Konukoglu D, Serin O, Yelke HK. (2000) Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women. J. Toxicol. Environ. Health A 60, 81-87. https://doi.org/10.1080/009841000156501
  33. Kuo SM. (1996) Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110, 41-48. https://doi.org/10.1016/S0304-3835(96)04458-8
  34. Kurzer MS, Xu Xia. (1997) Dietary Phytoestrogens. Annu. Rev. Nutr. 17, 353-381. https://doi.org/10.1146/annurev.nutr.17.1.353
  35. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. (1997) Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol. Pharmacol. 51, 193-200.
  36. Lamartiniere CA, Moore J, Holland M, Barnes S. (1995) Neonatal genistein chemoprevents mammary cancer. Proc. Soc, Exp. Biol. Med. 208, 120-123.
  37. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX, Barnes S, Zhang X, Wei H, Brown NM. (1998) Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc. Soc. Exp. Biol. Med. 217, 358-364.
  38. Le Bail JC, Varnat F, Nicolas JC, Habrioux G. (1998) Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130, 209-216. https://doi.org/10.1016/S0304-3835(98)00141-4
  39. Lian FL, Bhuiyan M, Li YW, Wall N, Kraut M, Sarkar FH. (1998) Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small lung cancer cell line. Nutr. Cancer 31, 184-191. https://doi.org/10.1080/01635589809514701
  40. Lian Z, Niwa K, Tagami K, Hashimoto M, Gao J, Yokoyama Y, Mori H, Tamaya T. (2001) Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn. J. Cancer Res. 92, 726-734.
  41. Lu A, Ran Rq, Clark J, Reilly M, Nee A, Sharp FR. (2002) 17-$\beta$-estradiol induces heat shock proteins in brain arteries and potentiates ischemic heat shock protein induction in glia and neurons. J. Cerebral Blood Flow Metab. 22, 183-195.
  42. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res. 53, 1328-1331.
  43. Middleton E, Kandaswami C. (1992) Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43, 1167-1179. https://doi.org/10.1016/0006-2952(92)90489-6
  44. Middleton E. (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 439, 175-182.
  45. Mitchell JH, Duthie SJ, Collins AR. (2000) Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP. Nutr. Cancer 38, 223-228. https://doi.org/10.1207/S15327914NC382_12
  46. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. (1998). Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Bochem. Biophys. 360, 142-148. https://doi.org/10.1006/abbi.1998.0951
  47. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K. (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142, 251-259. https://doi.org/10.1677/joe.0.1420251
  48. Peterson G, Barnes S. (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22, 335-345. https://doi.org/10.1002/pros.2990220408
  49. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. (1996) Flavonoids activate wild-type p53. Oncogene 13, 1605-1614.
  50. Price KR, Fenwick GR. (1985) Naturally occurring oestrogens in foods-a review. Food Addit. Contam. 2, 73-106.
  51. Ruiz-Larrea MB, Mohan AA, Paganga G, Miller NJ, Bolwell GC, Rice-Evans CA. (1997) Antioxidant acitivy of phytoestrogenic isoflavones. Free Radic. Res. 26, 63-70. https://doi.org/10.3109/10715769709097785
  52. Ruiz-Larrea MB, Martin C, Martinez R, Navarro R, Lacort M, Miller NJ. (2000). Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem. Phys. Lipid 105, 179-188. https://doi.org/10.1016/S0009-3084(00)00120-1
  53. Santti R, Makela S, Strauss L, Korkman J, Kostian ML. (1998) Phyto-oestrogens: potential endocrine disruptors in males.Toxicol. Industrial Health 14, 223-237.
  54. Setchell KDR, Adlercreutz H. (1988) Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in the health and diseases. In Role of gut for a in toxicity and cancer, pp. 315-345, Academic Press, London.
  55. Shutt DA, Cox RI. (1972) Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J. Endocrinol. 52, 299-310. https://doi.org/10.1677/joe.0.0520299
  56. Smith TJ, Yang CS. (1994) Effects of food phytochemical on xenobiotic metabolism and tumorigenesis. In Food Phytochemicals I: Fruits and Vegetables, pp. 18-41, American Chemical Society.
  57. Stephens FO. (1997) Phytooestrogens and prostate cancer: possible preventive role. Med. J. Aust. 167, 138-139.
  58. Tham DM, Gardner CD, Haskell WL. (1998) Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83, 22223-22232.
  59. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. (1998) Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. U.S.A. 95, 3106-3110. https://doi.org/10.1073/pnas.95.6.3106
  60. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. (1992) Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52, 6200-6208.
  61. Van Thiel DH, Galvao-Teles A, Monteiro E, Rosenblum E, Gavaler JS. (1991) The phytoestrogens present in de-ethanolized bourbon are biologically active: a preliminary study in a postmenopausal woman. Alcoholism Clin. Exp. Res. 15, 822-823. https://doi.org/10.1111/j.1530-0277.1991.tb00608.x
  62. Wang W, Higuchi CM, Zhang R. (1997) Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lympocyte activation. Nutr. Cancer 29, 29-34. https://doi.org/10.1080/01635589709514598
  63. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208, 124-130.
  64. Wei H, Wei L, Bowen R, Frenkel K, Barnes S. (1993) Inhibition of tumor promotion-induced hydrogen peroxide production in vitro and in vivo by genistein. Nutr. Cancer 20, 1-12.
  65. Wei HC, Bowen R, Zhang XS, Lebwohl M. (1998) Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 19, 1509-1514. https://doi.org/10.1093/carcin/19.8.1509
  66. Wei HC, Cai QY, Rahn RO. (1996) Inhibition of UV light and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis 17, 73-77. https://doi.org/10.1093/carcin/17.1.73
  67. Widyarini S, Husband AJ, Reeve VE. (2005). Protective Effect of Isoflavonoid Equol Against Hairless Mouse Skin Carcinogenesis Induced by UV Radiation Alone or with a Chemical Cocarcinogen. Photochem. Photobiol. 81, 32-37. https://doi.org/10.1562/2004-06-02-RA-183.1
  68. Widyarini S, Spinks N, Husband AJ, Reeve VE. (2001) Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation. Photochem. Photobiol. 74, 465-470. https://doi.org/10.1562/0031-8655(2001)074<0465:ICFRCT>2.0.CO;2
  69. Wiseman H. (1999) The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens. Proc. Nutr. Soc. 58, 139-146. https://doi.org/10.1079/PNS19990019
  70. Zhang R, Li Y, Wang W. (1997) Enhancement of immune function in mice fed high doses of soy daidzein. Nutr. Cancer 29, 24-28. https://doi.org/10.1080/01635589709514597
  71. Zhang Y, Song TT, Cunnick JE, Murphy PA, Hendrick S. (1999) Daidzein and genistein glucoronides in vitro are weakly estrogenic and activate human natural killer cells in nutritionally relevant concentration. J. Nutr. 129, 399-405.
  72. Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK. (1998). Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58, 5231-5238.